Jonathan Yong
Stock Analyst at UBS
(2.64)
# 2,011
Out of 4,853 analysts
104
Total ratings
60%
Success rate
10.49%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Neutral | $9.5 → $7 | $4.40 | +59.09% | 5 | May 8, 2025 | |
| CLOV Clover Health Investments | Initiates: Neutral | $4 | $3.08 | +29.87% | 3 | Oct 7, 2024 | |
| OSCR Oscar Health | Initiates: Neutral | $23 | $14.15 | +62.54% | 7 | Oct 7, 2024 | |
| PINC Premier | Maintains: Neutral | $33 → $25 | $23.17 | +7.92% | 2 | Aug 24, 2023 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $33 → $30 | $11.25 | +166.67% | 5 | Aug 24, 2023 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $10.62 | +12.99% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $4.01 | +99.50% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $12.86 | +102.18% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $53.61 | -73.89% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $70.36 | +36.44% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $32 | $15.24 | +109.97% | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $115 → $105 | $20.05 | +423.69% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $121.27 | -34.03% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $254.37 | -9.19% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $94.61 | +6.75% | 5 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $7.12 | +279.21% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $154.07 | -35.09% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $709.46 | -36.57% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $3.56 | +237.55% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $6.92 | +911.56% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $14.26 | +19.26% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $292.61 | +19.61% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $22.60 | +320.35% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $5.91 | +43.82% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $23.02 | +78.11% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $6.66 | +155.26% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.83 | +121.93% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $78.06 | +8.89% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $173.81 | -16.00% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $54.94 | +92.94% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $188.65 | -16.78% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $310.12 | +18.66% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $230.83 | +175.09% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $63.57 | +84.05% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $13.90 | +115.83% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $381.66 | -21.92% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $169.89 | -44.08% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $300.38 | +64.79% | 1 | Oct 15, 2021 |
eHealth
May 8, 2025
Maintains: Neutral
Price Target: $9.5 → $7
Current: $4.40
Upside: +59.09%
Clover Health Investments
Oct 7, 2024
Initiates: Neutral
Price Target: $4
Current: $3.08
Upside: +29.87%
Oscar Health
Oct 7, 2024
Initiates: Neutral
Price Target: $23
Current: $14.15
Upside: +62.54%
Premier
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $25
Current: $23.17
Upside: +7.92%
Walgreens Boots Alliance
Aug 24, 2023
Maintains: Neutral
Price Target: $33 → $30
Current: $11.25
Upside: +166.67%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $10.62
Upside: +12.99%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $4.01
Upside: +99.50%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $12.86
Upside: +102.18%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $53.61
Upside: -73.89%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $70.36
Upside: +36.44%
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $15.24
Upside: +109.97%
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $20.05
Upside: +423.69%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $121.27
Upside: -34.03%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $254.37
Upside: -9.19%
Jul 27, 2023
Reiterates: Neutral
Price Target: $101
Current: $94.61
Upside: +6.75%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $7.12
Upside: +279.21%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $154.07
Upside: -35.09%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $709.46
Upside: -36.57%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $3.56
Upside: +237.55%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $6.92
Upside: +911.56%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $14.26
Upside: +19.26%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $292.61
Upside: +19.61%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $22.60
Upside: +320.35%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $5.91
Upside: +43.82%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $23.02
Upside: +78.11%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $6.66
Upside: +155.26%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.83
Upside: +121.93%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $78.06
Upside: +8.89%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $173.81
Upside: -16.00%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $54.94
Upside: +92.94%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $188.65
Upside: -16.78%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $310.12
Upside: +18.66%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $230.83
Upside: +175.09%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $63.57
Upside: +84.05%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $13.90
Upside: +115.83%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $381.66
Upside: -21.92%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $169.89
Upside: -44.08%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $300.38
Upside: +64.79%